Venous Thromboembolism
Fondaparinux highly effective as VT prophylaxis in orthopedic surgery
Published in Blood Weekly, November 4th, 2004
Researchers in the Netherlands examined data from "all completed studies evaluating pentasaccharides - synthetically derived, selective inhibitors of activated factor X - in prophylaxis in major orthopedic surgery and the treatment of venous thromboembolism."
"Venous thromboembolism is a disorder with considerable morbidity when left untreated," explained M. Nijkeuter and coauthors at Leiden University. "The pentasaccharides fondaparinux and idraparinux are the first of a new class of synthetic selective inhibitors of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-11-04)
More Articles from Blood Weekly
- Hematology
Analyses reveal siblings with rare double clotting deficiencies - Organ Banking
Organ procurement after poisoning deather studied - Sphingolipidoses
Sphingolipidoses are relatively common and important health problem in Turkey - Tissue Engineering
Scaffold topography alters cardiomyocyte network intracellular calcium dynamics - Transplant Medicine
Placental blood cell transplant feasible in children with sickle cell disease - Acinetobacter Baumannii
Multiresistant Acinetobacter baumannii outbreak occurred in surgical room - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
